These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 7006545

  • 1. Recovery from rapidly progressive glomerulonephritis. Improvement after plasmapheresis and immunosuppression.
    Warren SE, Mitas JA, Golbus SM, Swerdlin AR, Cohen IM, Cronin RE.
    Arch Intern Med; 1981 Feb; 141(2):175-80. PubMed ID: 7006545
    [Abstract] [Full Text] [Related]

  • 2. Predictive value of initial histology and effect of plasmapheresis on long-term prognosis of rapidly progressive glomerulonephritis.
    Zäuner I, Bach D, Braun N, Krämer BK, Fünfstück R, Helmchen U, Schollmeyer P, Böhler J.
    Am J Kidney Dis; 2002 Jan; 39(1):28-35. PubMed ID: 11774098
    [Abstract] [Full Text] [Related]

  • 3. [Rapidly progressive glomerular disease treated with plasmapheresis (author's transl)].
    Praga M, Mijares R, Elósegui A, de los Mozos J, Ochoa de Olza M, Cortabitarte N, López de Novales E.
    Med Clin (Barc); 1981 Jun 10; 77(1):33-6. PubMed ID: 7253760
    [Abstract] [Full Text] [Related]

  • 4. Effect of early plasmapheresis and immunosuppressive therapy on natural history of anti-glomerular basement membrane glomerulonephritis: report of a 22-month follow-up.
    Bruns FJ, Stachura I, Adler S, Segel DP.
    Arch Intern Med; 1979 Mar 10; 139(3):372-4. PubMed ID: 426585
    [Abstract] [Full Text] [Related]

  • 5. [A case of anti-GBM-antibody positive rapidly progressive glomerulonephritis who was weaned from hemodialysis after combination therapy with steroid and plasmapheresis].
    Kitaura K, Asano K.
    Nihon Jinzo Gakkai Shi; 2005 Mar 10; 47(8):887-92. PubMed ID: 16408434
    [Abstract] [Full Text] [Related]

  • 6. A case report of efficiency of double filtration plasmapheresis in treatment of Goodpasture's syndrome.
    Hajime N, Michiko A, Atsunori K, Tatsuo K, Yuko N, Naoki O, Katsuhiko S.
    Ther Apher Dial; 2009 Aug 10; 13(4):373-7. PubMed ID: 19695077
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Rapid progressive glomerulonephritis: relapse after prolonged remission.
    Adler S, Bruns FJ, Fraley DS, Segel DP.
    Arch Intern Med; 1981 Jun 10; 141(7):852-4. PubMed ID: 7235804
    [Abstract] [Full Text] [Related]

  • 9. Plasma exchange and immunosuppression in rapidly progressive glomerulonephritis: a controlled, multi-center study.
    Glöckner WM, Sieberth HG, Wichmann HE, Backes E, Bambauer R, Boesken WH, Bohle A, Daul A, Graben N, Keller F.
    Clin Nephrol; 1988 Jan 10; 29(1):1-8. PubMed ID: 3289804
    [Abstract] [Full Text] [Related]

  • 10. [Anti-basement-membrane antibody mediated, rapidly progressive, glomerulonephritis. Diagnostic and therapeutic strategy based on a retrospective study of 14 cases].
    Bouget J, Le Pogamp P, Perrier G, Ramée MP, Rivalan J, Camus C, Thomas R, Chevet D.
    Ann Med Interne (Paris); 1990 Jan 10; 141(5):409-15. PubMed ID: 2256583
    [Abstract] [Full Text] [Related]

  • 11. Plasmapheresis in rapidly progressive Henoch-Schoenlein glomerulonephritis and the effect on circulating IgA immune complexes.
    Kauffmann RH, Houwert DA.
    Clin Nephrol; 1981 Sep 10; 16(3):155-60. PubMed ID: 7296974
    [Abstract] [Full Text] [Related]

  • 12. Clinical and morphological aspects of the management of crescentic anti-glomerular basement membrane antibody (anti-GBM) nephritis/Goodpasture's syndrome.
    Walker RG, Scheinkestel C, Becker GJ, Owen JE, Dowling JP, Kincaid-Smith P.
    Q J Med; 1985 Jan 10; 54(213):75-89. PubMed ID: 3975346
    [Abstract] [Full Text] [Related]

  • 13. [Plasmapheresis in the treatment of rapidly progressing glomerulonephritis].
    Milovanov IuS, Komiagin IuV, Shilov EM, Ermolenko VM.
    Ter Arkh; 1989 Jan 10; 61(6):78-81. PubMed ID: 2799722
    [Abstract] [Full Text] [Related]

  • 14. [Simultaneous presence of antibodies against the glomerular basement membrane and anti-myeloperoxidase antibodies in 2 patients with rapidly progressive glomerulonephritis].
    Díaz Rodríguez C, Costero O, Torre A, De Alvaro F, Gil F, Picazo ML, Martínez-Ara J.
    Nefrologia; 2002 Jan 10; 22(2):190-5. PubMed ID: 12085420
    [Abstract] [Full Text] [Related]

  • 15. Coexistent anti-neutrophil cytoplasmic antibody and antiglomerular basement membrane antibody associated disease = report of six cases.
    Bonsib SM, Goeken JA, Kemp JD, Chandran P, Shadur C, Wilson L.
    Mod Pathol; 1993 Sep 10; 6(5):526-30. PubMed ID: 8248108
    [Abstract] [Full Text] [Related]

  • 16. [Plasmapheresis in the treatment of extracapillary glomerulonephritis (author's transl)].
    Sanz Guajardo D, Barbolla ML, Fernández Fernández J, Gallego JL, Anaya A, Botella J.
    Med Clin (Barc); 1980 May 10; 74(9):337-41. PubMed ID: 7382624
    [Abstract] [Full Text] [Related]

  • 17. A case report of plasmapheresis and cyclophosphamide for steroid-resistant focal segmental glomerulosclerosis: recovery of renal function after five months on dialysis.
    Oliveira L, Wang D, McCormick BB.
    Ther Apher Dial; 2007 Jun 10; 11(3):227-31. PubMed ID: 17498006
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of prognostic factors for myeloperoxidase anti-neutrophil cytoplasmic antibody- (MPO-ANCA) associated glomerulonephritis.
    Okano K, Yumura W, Nitta K, Honda K, Uchida K, Nihei H.
    Clin Nephrol; 2001 Apr 10; 55(4):275-81. PubMed ID: 11334312
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Relapse in anti glomerular basement membrane antibody mediated crescentic glomerulonephritis.
    Wu MJ, Moorthy AV, Beirne GJ.
    Clin Nephrol; 1980 Feb 10; 13(2):97-102. PubMed ID: 7363520
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.